IL31 and Alzheimer disease: Patients with moderate-to-severe AD harbor systemic inflammation/immune abnormalities such as strong Th2 activation, expansion of T cell subsets, and increased levels of pro-inflammatory cytokines, including interleukin (IL)-4, IL-13, and IL-31 [7,8,9,10,11,12,13,14].